Preventing Infections in Cancer Patients

Call your doctor right away if you get a fever or feel sick during your chemotherapy treatment.

Health & Lifestyle
604

Listen to article (english)

Translate to Spanish or other 102 languages!

An infection can lead to sepsis, the body’s extreme response to an infection. It is a life-threatening medical emergency. Image for illustration purposes
An infection can lead to sepsis, the body’s extreme response to an infection. It is a life-threatening medical emergency. Image for illustration purposes

Mega Doctor News

- Advertisement -

People with cancer who are treated with chemotherapy are more likely to get infections. Your immune system helps your body protect itself from getting an infection. Cancer and chemotherapy can damage this system by reducing the number of infection-fighting white blood cells. This condition is called neutropenia.

An infection can lead to sepsis, the body’s extreme response to an infection. It is a life-threatening medical emergency.

Find out from your doctor when your white blood cell count is likely to be lowest, since this is when you’re most at risk for infection. This usually occurs between 7 and 12 days after you finish each chemotherapy dose, and may last as long as one week.

- Advertisement -

Information Source: CDC

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
Improving Prediction of Advanced Breast Cancer Among Women of Different Races and Ethnicities
Next article
High Demand for Health Care Careers In The RGV

More Articles

New Stemless Shoulder Replacement Preserves Bone and Speeds Recovery

atients suffering from shoulder pain and loss of motion due to osteoarthritis have often relied on shoulder replacement surgery to provide pain relief and restore function when nonoperative treatment has failed.

What Persistent Fatigue Might Be Telling You

Mega Doctor News CLEVELAND CLINIC - We’ve all had those days where we’re...

AMA Unveils New Initiative to Boost Nutrition Education Nationwide

The American Medical Association (AMA) is launching a nutrition education initiative to equip physicians and medical students with practical, evidence-based knowledge and tools to help patients live healthier lives.

Study Finds GLP‑1 Therapy Reduces Heart and Kidney Risks for Type 1 Diabetes Patients

People with type 1 diabetes who took GLP-1 receptor agonist (GLP-1-RA) drugs for weight loss or better blood-sugar control had significantly reduced risks of major cardiovascular events and end-stage kidney disease without any increase in safety concerns, according to a study led by researchers at the Johns Hopkins Bloomberg School of Public Health.
- Advertisement -